Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
111465032 | 11146503 | 2 | F | 20160811 | 20150528 | 20160823 | EXP | CA-APOTEX-2015AP009443 | APOTEX | 84.00 | YR | F | Y | 0.00000 | 20160823 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
111465032 | 11146503 | 1 | SS | APO-TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | 50 MG, Q.H.S. | Y | 0 | 50 | MG | TABLET | QD | |||||
111465032 | 11146503 | 2 | SS | APO-TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | 25 MG, Q.H.S. PRN | Y | 0 | 50 | MG | TABLET | QD | |||||
111465032 | 11146503 | 3 | PS | APO-CANDESARTAN | CANDESARTAN | 1 | Unknown | 4 MG, Q.AM | Y | 202079 | 4 | MG | TABLET | QD | |||||
111465032 | 11146503 | 4 | SS | APO-CETIRIZINE 10MG TABS | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | 20 MG, DAILY | Y | 0 | 20 | MG | |||||||
111465032 | 11146503 | 5 | SS | APO-BETAHISTINE | BETAHISTINE HYDROCHLORIDE | 1 | Unknown | 8 MG, TID | Y | 0 | 8 | MG | TABLET | TID | |||||
111465032 | 11146503 | 6 | SS | APO-BETAHISTINE | BETAHISTINE HYDROCHLORIDE | 1 | Unknown | 8 MG, BID | Y | 0 | 8 | MG | TABLET | BIW | |||||
111465032 | 11146503 | 7 | SS | APO-BETAHISTINE | BETAHISTINE HYDROCHLORIDE | 1 | Unknown | 8 MG, DAILY | Y | 0 | 8 | MG | TABLET | ||||||
111465032 | 11146503 | 8 | SS | APO-BISOPROLOL 5MG TABLETS | BISOPROLOL FUMARATE | 1 | Unknown | 1.25 MG, EVERY MORNING | Y | 0 | 1.25 | MG | TABLET | QD | |||||
111465032 | 11146503 | 9 | SS | APO-METOCLOP | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | 10 MG, TID | Y | 0 | 10 | MG | TABLET | TID | |||||
111465032 | 11146503 | 10 | SS | APO DIMENHYDRINATE | DIMENHYDRINATE | 1 | Unknown | 50 MG, PRN | Y | 0 | 50 | MG | TABLET | ||||||
111465032 | 11146503 | 11 | SS | APO-ROSUVASTATIN | ROSUVASTATIN | 1 | Unknown | 20 MG, QD | Y | 0 | 20 | MG | TABLET | ||||||
111465032 | 11146503 | 12 | SS | APO-MIRTAZAPINE | MIRTAZAPINE | 1 | Unknown | 7.5 MG, Q.H.S. | Y | 0 | 7.5 | MG | TABLET | QD | |||||
111465032 | 11146503 | 13 | SS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG, DAILY | U | U | 0 | 40 | MG | ||||||
111465032 | 11146503 | 14 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 5 MG, DAILY | Y | 0 | 5 | MG | |||||||
111465032 | 11146503 | 15 | SS | APO-TIMOP | TIMOLOL MALEATE | 1 | Ophthalmic | 1 DF, IN BOTH EYES BID | U | U | 0 | 1 | DF | BID | |||||
111465032 | 11146503 | 16 | SS | APO-LEVOCARB | CARBIDOPALEVODOPA | 1 | Unknown | 100MG LEVODOPA/25MG CARBIDOPA 2 DF TID | U | U | 0 | 2 | DF | TABLET | TID | ||||
111465032 | 11146503 | 17 | SS | APO-RISEDRONATE | RISEDRONATE SODIUM | 1 | Unknown | 150 MG, Q.M.T. | U | U | 0 | 150 | MG | TABLET | /month | ||||
111465032 | 11146503 | 18 | SS | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Unknown | 1000 U DAILY | U | U | 0 | 1000 | IU | ||||||
111465032 | 11146503 | 19 | SS | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Unknown | 0.05 MG/DAY | U | U | 0 | .05 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
111465032 | 11146503 | 1 | Insomnia |
111465032 | 11146503 | 3 | Hypertension |
111465032 | 11146503 | 4 | Eye pruritus |
111465032 | 11146503 | 5 | Vertigo |
111465032 | 11146503 | 8 | Product used for unknown indication |
111465032 | 11146503 | 9 | Diverticulitis |
111465032 | 11146503 | 10 | Nausea |
111465032 | 11146503 | 11 | Haemorrhagic stroke |
111465032 | 11146503 | 12 | Depressed mood |
111465032 | 11146503 | 13 | Nausea |
111465032 | 11146503 | 14 | Depressed mood |
111465032 | 11146503 | 15 | Glaucoma |
111465032 | 11146503 | 16 | Parkinson's disease |
111465032 | 11146503 | 17 | Osteoporosis |
111465032 | 11146503 | 18 | Osteoporosis |
111465032 | 11146503 | 19 | Hypothyroidism |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
111465032 | 11146503 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
111465032 | 11146503 | Abdominal distension | |
111465032 | 11146503 | Activities of daily living impaired | |
111465032 | 11146503 | Condition aggravated | |
111465032 | 11146503 | Constipation | |
111465032 | 11146503 | Decreased appetite | |
111465032 | 11146503 | Depressed mood | |
111465032 | 11146503 | Dizziness | |
111465032 | 11146503 | Drug ineffective | |
111465032 | 11146503 | Dry mouth | |
111465032 | 11146503 | Eye pruritus | |
111465032 | 11146503 | Fall | |
111465032 | 11146503 | Fatigue | |
111465032 | 11146503 | Hypersensitivity | |
111465032 | 11146503 | Hypotension | |
111465032 | 11146503 | Lacrimation increased | |
111465032 | 11146503 | Nausea | |
111465032 | 11146503 | Parkinson's disease | |
111465032 | 11146503 | Vertigo | |
111465032 | 11146503 | Vitamin B12 decreased | |
111465032 | 11146503 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |